Lupin Pharmaceuticals Inc. 2026-07-08 Health serious FDA
Health · FDA · Recall #FDA-D-0723-2026
Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial,… Recall
Issued July 8, 2026 · Lupin Pharmaceuticals Inc.
In July 2026, Lupin Pharmaceuticals Inc. recalled the Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial,…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Dana Whitfield, RecallCheckr
What this means for you
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
What you should do
- 1 Stop using Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Lupin Pharmaceuticals Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Lupin Pharmaceuticals Inc.
- Category
- Health
- Recall date
- July 8, 2026
- Units affected
- Not reported
- Sold at
- Nationwide within the U.S.
- Recall number
- FDA-D-0723-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Lupin Pharmaceuticals Inc. has 21 recalls in our database, including 1 rated Critical.
- We're tracking 3,673 Health recalls in our database.
- This is the 453rd Health recall we've logged in 2026.